ticlopidine has been researched along with Epistaxis in 11 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Epistaxis: Bleeding from the nose.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The occurrence of epistaxis is followed by premature discontinuation of clopidogrel therapy by one fifth of patients after coronary angioplasty and DES implantation." | 7.77 | Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation. ( Chudek, J; Jura-Szołtys, E, 2011) |
| "To quantify the relative risk of epistaxis for patients taking low-dose aspirin or clopidogrel compared to patients taking neither drug." | 7.75 | Clopidogrel versus low-dose aspirin as risk factors for epistaxis. ( Molony, NC; Rainsbury, JW, 2009) |
| "Ticlopidine (Ticlid@) is a platelet aggregation inhibitor that can produce bleeding or severe hemorrhage as a side-effect." | 5.32 | [Severe epistaxis secondary to ticlopidine. Report of 3 cases]. ( Blasco Huelva, A; González Palomino, A; Keituqwa Yáñez, T; Marcos García, M; Pardo Romero, G; Pino Rivero, V; Trinidad Ruíz, G, 2004) |
| " A PubMED and Cochrane Library search was performed on 10/03/16 using, but not limited to, the search terms epistaxis, nosebleed, nose bleeding, nasal haemorrhage, nasal bleeding AND each of the following search terms: antithrombotic, anticoagulant, antiplatelet, aspirin, clopidogrel, warfarin, dabigatran, rivaroxaban, apixaban and tranexamic acid." | 4.93 | A systematic review of anti-thrombotic therapy in epistaxis. ( Musgrave, KM; Powell, J, 2016) |
| " The occurrence of epistaxis is followed by premature discontinuation of clopidogrel therapy by one fifth of patients after coronary angioplasty and DES implantation." | 3.77 | Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation. ( Chudek, J; Jura-Szołtys, E, 2011) |
| " A 35-year-old lady with ES taking aspirin with clopidogrel for thrombo-prophylaxis presented with massive epistaxis." | 3.77 | Massive epistaxis in a patient with Eisenmenger syndrome: illustrating the clot-versus-bleed conundrum. ( Liu, A; Pusalkar, P; Saman, H, 2011) |
| "To quantify the relative risk of epistaxis for patients taking low-dose aspirin or clopidogrel compared to patients taking neither drug." | 3.75 | Clopidogrel versus low-dose aspirin as risk factors for epistaxis. ( Molony, NC; Rainsbury, JW, 2009) |
| " The lack of a clinically meaningful effect of high-dose atorvastatin on the pharmacodynamic response to prasugrel after the loading or maintenance dose indicates that no dosage adjustment should be necessary in patients receiving these drugs concomitantly." | 2.73 | Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects. ( Brandt, JT; Ernest, CS; Farid, NA; Jakubowski, JA; Konkoy, CS; Li, YG; Payne, CD; Salazar, DE; Small, DS; Winters, KJ, 2008) |
| "Recurrent epistaxis is a rare presentation of internal carotid artery C4/C5 segment pseudo-aneurysm rupture." | 1.40 | Endovascular treatment of internal carotid artery pseudo-aneurysm presenting with epistaxis. A case report. ( Bazina, A; Hucika, Z; Mišmaš, A; Pavliša, G; Poljaković, Z, 2014) |
| "Ticlopidine (Ticlid@) is a platelet aggregation inhibitor that can produce bleeding or severe hemorrhage as a side-effect." | 1.32 | [Severe epistaxis secondary to ticlopidine. Report of 3 cases]. ( Blasco Huelva, A; González Palomino, A; Keituqwa Yáñez, T; Marcos García, M; Pardo Romero, G; Pino Rivero, V; Trinidad Ruíz, G, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazina, A | 1 |
| Mišmaš, A | 1 |
| Hucika, Z | 1 |
| Pavliša, G | 1 |
| Poljaković, Z | 1 |
| Musgrave, KM | 1 |
| Powell, J | 1 |
| Farid, NA | 1 |
| Small, DS | 1 |
| Payne, CD | 1 |
| Jakubowski, JA | 1 |
| Brandt, JT | 1 |
| Li, YG | 1 |
| Ernest, CS | 1 |
| Salazar, DE | 1 |
| Konkoy, CS | 1 |
| Winters, KJ | 1 |
| Rainsbury, JW | 1 |
| Molony, NC | 1 |
| Smith, J | 1 |
| Siddiq, S | 1 |
| Dyer, C | 1 |
| Rainsbury, J | 1 |
| Kim, D | 1 |
| Jura-Szołtys, E | 1 |
| Chudek, J | 1 |
| Wysocki, H | 1 |
| Liu, A | 1 |
| Saman, H | 1 |
| Pusalkar, P | 1 |
| Nácul, FE | 1 |
| de Moraes, E | 1 |
| Penido, C | 1 |
| Paiva, RB | 1 |
| Méier-Neto, JG | 1 |
| Pino Rivero, V | 1 |
| Marcos García, M | 1 |
| Trinidad Ruíz, G | 1 |
| Keituqwa Yáñez, T | 1 |
| Pardo Romero, G | 1 |
| González Palomino, A | 1 |
| Blasco Huelva, A | 1 |
| Macdonald, J | 1 |
| Srinivasan, M | 1 |
| More, R | 1 |
2 reviews available for ticlopidine and Epistaxis
| Article | Year |
|---|---|
A systematic review of anti-thrombotic therapy in epistaxis.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Clopidogrel; Dabigatran; Disease Management; Epist | 2016 |
Percutaneous coronary intervention in a patient with von Willebrand's disease presenting with an acute coronary syndrome.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Coronary Angiography; Co | 2006 |
1 trial available for ticlopidine and Epistaxis
| Article | Year |
|---|---|
Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.
Topics: Adolescent; Adult; Anticholesteremic Agents; Area Under Curve; Atorvastatin; Chromatography, Liquid; | 2008 |
8 other studies available for ticlopidine and Epistaxis
| Article | Year |
|---|---|
Endovascular treatment of internal carotid artery pseudo-aneurysm presenting with epistaxis. A case report.
Topics: Angiography, Digital Subtraction; Aspirin; Carotid Artery Injuries; Carotid Artery, Internal; Clopid | 2014 |
Clopidogrel versus low-dose aspirin as risk factors for epistaxis.
Topics: Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Epistaxis; Humans; Hypertension; Myocardial | 2009 |
Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Com | 2011 |
Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Epistaxis; Female; Humans; Logistic Models; Male; | 2011 |
[Use of clopidogrel after PCI--why do patients quit?].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Epistaxis; Female; Humans; Male; Platelet Aggregation I | 2011 |
Massive epistaxis in a patient with Eisenmenger syndrome: illustrating the clot-versus-bleed conundrum.
Topics: Adult; Aspirin; Clopidogrel; Eisenmenger Complex; Epistaxis; Female; Humans; Platelet Aggregation In | 2011 |
Massive nasal bleeding and hemodynamic instability associated with clopidogrel.
Topics: Clopidogrel; Deamino Arginine Vasopressin; Epistaxis; Female; Hemodynamics; Hemostatics; Humans; Isc | 2004 |
[Severe epistaxis secondary to ticlopidine. Report of 3 cases].
Topics: Aged; Aged, 80 and over; Epistaxis; Humans; Male; Platelet Aggregation Inhibitors; Tampons, Surgical | 2004 |